glucose, (beta-d)-isomer has been researched along with Laryngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; He, X; Wang, DH | 1 |
| Li, H; Li, Y; Shi, B; Yin, F | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Laryngeal Neoplasms
| Article | Year |
|---|---|
Combining use of Phillyrin and autophagy blocker alleviates laryngeal squamous cell carcinoma via AMPK/mTOR/p70S6K signaling.
Topics: Adenine; AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Chloroquine; Glucosides; Humans; Laryngeal Neoplasms; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.
Topics: Animals; Cell Proliferation; Fallopia japonica; Female; Glucosides; HeLa Cells; Humans; Laryngeal Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2017 |